1. Home
  2. OLO vs ARDX Comparison

OLO vs ARDX Comparison

Compare OLO & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLO
  • ARDX
  • Stock Information
  • Founded
  • OLO 2005
  • ARDX 2007
  • Country
  • OLO United States
  • ARDX United States
  • Employees
  • OLO N/A
  • ARDX N/A
  • Industry
  • OLO Major Banks
  • ARDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • OLO Finance
  • ARDX Health Care
  • Exchange
  • OLO Nasdaq
  • ARDX Nasdaq
  • Market Cap
  • OLO 1.0B
  • ARDX 882.9M
  • IPO Year
  • OLO 2021
  • ARDX 2014
  • Fundamental
  • Price
  • OLO $10.12
  • ARDX $4.65
  • Analyst Decision
  • OLO Buy
  • ARDX Strong Buy
  • Analyst Count
  • OLO 3
  • ARDX 9
  • Target Price
  • OLO $10.17
  • ARDX $10.17
  • AVG Volume (30 Days)
  • OLO 4.7M
  • ARDX 4.5M
  • Earning Date
  • OLO 07-30-2025
  • ARDX 07-31-2025
  • Dividend Yield
  • OLO N/A
  • ARDX N/A
  • EPS Growth
  • OLO N/A
  • ARDX N/A
  • EPS
  • OLO 0.01
  • ARDX N/A
  • Revenue
  • OLO $299,107,000.00
  • ARDX $361,706,000.00
  • Revenue This Year
  • OLO $20.21
  • ARDX $11.39
  • Revenue Next Year
  • OLO $17.90
  • ARDX $32.84
  • P/E Ratio
  • OLO $946.08
  • ARDX N/A
  • Revenue Growth
  • OLO 23.31
  • ARDX 127.33
  • 52 Week Low
  • OLO $4.32
  • ARDX $3.21
  • 52 Week High
  • OLO $10.15
  • ARDX $7.18
  • Technical
  • Relative Strength Index (RSI)
  • OLO 75.49
  • ARDX 64.55
  • Support Level
  • OLO $8.50
  • ARDX $4.14
  • Resistance Level
  • OLO $10.15
  • ARDX $4.71
  • Average True Range (ATR)
  • OLO 0.20
  • ARDX 0.19
  • MACD
  • OLO 0.11
  • ARDX 0.11
  • Stochastic Oscillator
  • OLO 98.21
  • ARDX 81.97

About OLO Olo Inc.

Olo Inc is an open Software as a Service platform for restaurants. Its platform powers restaurant brands' on-demand digital commerce operations, enabling digital ordering, delivery, front-of-house management, and payments, while further strengthening and enhancing restaurants' direct guest relationships. The company generates revenue from providing its customers access to its platform.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: